###begin article-title 0
###xml 98 120 98 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 84 92 <span type="species:ncbi:9606">children</span>
###xml 98 119 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Opposed circulating plasma levels of endothelin-1 and C-type natriuretic peptide in children with Plasmodium falciparum malaria
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 60 82 60 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 60 81 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Molecular mechanisms involved in the pathogenesis of severe Plasmodium falciparum malaria (SM), are not yet fully understood. Both endothelin-1 (ET-1) and C-type natriuretic peptide (CNP) are produced by vascular endothelium and act locally as paracrine regulators of vascular tone, ET-1 being a potent vasoconstrictor and CNP having strong vasorelaxant properties.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 241 243 241 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 282 284 282 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 316 318 316 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 196 204 <span type="species:ncbi:9606">children</span>
Plasma levels of ET-1 and N-terminal fragments of CNP (NT-proCNP) were studied on admission and after 24 hours of treatment, using enzyme-linked-immunosorbent-assay (ELISA) technique, in Gabonese children with severe falciparum malaria (SM, n = 50), with uncomplicated malaria (UM, n = 39) and healthy controls (HC, n = 25).
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 125 127 125 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 139 141 139 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 250 252 250 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 387 389 387 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 24 32 <span type="species:ncbi:9606">patients</span>
###xml 225 233 <span type="species:ncbi:9606">patients</span>
Compared to HC, malaria patients had significantly higher plasma levels of ET-1 and significantly lower levels of NT-proCNP (p < 0.001 and p < 0.024 respectively). Plasma levels of NT-proCNP were additionally decreased in SM patients compared to HC (p = 0.034), whereas UM was not significantly different to HC. In the SM group we found a trend towards lower ET-1 levels compared to UM (p = 0.085).
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 142 150 <span type="species:ncbi:9606">children</span>
In the present study, an imbalance between the vasoconstricitve and vasorelaxant endothelium-derived substances ET-1 and CNP in the plasma of children with falciparum malaria is demonstrated, presumably in favor of vasoconstrictive and pro-inflammatory effects. These results may indicate involvement of ET-1 and CNP in malaria pathogenesis. Furthermore, results of lower ET-1 and CNP levels in SM may reflect endothelial cell damage.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 186 187 186 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 190 212 190 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 16 19 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 190 211 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Malaria, beside HIV and tuberculosis, is still a major cause of death in developing countries, accounting for 300 - 500 million clinical cases and more than one million deaths per year [1]. Plasmodium falciparum may lead to severe malaria (SM), a complex clinical syndrome with yet incompletely understood pathomechanisms.
###end p 11
###begin p 12
###xml 100 101 100 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 102 103 102 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 501 502 501 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 674 675 674 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 743 744 743 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 949 950 949 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1046 1047 1046 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1048 1049 1048 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1154 1155 1154 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1156 1158 1156 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1178 1180 1178 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1215 1217 1215 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1394 1396 1394 1396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1475 1494 1475 1494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium berghei </italic>
###xml 1547 1549 1547 1549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1360 1368 <span type="species:ncbi:9606">patients</span>
###xml 1456 1460 <span type="species:ncbi:10090">mice</span>
###xml 1475 1493 <span type="species:ncbi:5821">Plasmodium berghei</span>
It has been shown that the endothelium is critically involved in the development of severe malaria [2-4]. The endothelial response to injury in acute inflammation can be divided into two phases: an initial rapid endothelial cell activation with recruitment of neutrophils, changes in levels of nitric oxide (NO), endothelin-1 (ET-1) and C-type natriuretic peptide (CNP) amongst others, and a slower response that depends on new gene expression and fundamental changes in cell surface characteristics [5]. Endothelins are regulators of vascular tone, amplifiers of inflammatory response and are involved in normal cell proliferation as well as repair and tissue development [6]. Endothelin-1 (ET-1) is a 21-amino acid vasoconstrictive peptide [6]. It is synthesized by vascular endothelial cells as well as neurons, astrocytes and other cells at low basal levels and ET-1 tissue expression is up-regulated in response to a variety of stress stimuli [6]. ET-1 can modulate the endothelial expression of adhesion molecules and cytokines production [7,8]. Moreover, ET-1 has been shown to be up-regulated in a variety of infectious diseases, such as sepsis [9,10], Chagas' disease [11] or community acquired pneumonia [12] In contrast, clinical data on ET-1 in malaria is limited. It has been shown that big ET-1, a 38-amino acid precursor of ET-1, is elevated in patients with falciparum malaria [13]. Further, experimental in vivo data indicate that C57Bl/6 mice infected with Plasmodium berghei ANKA showed markedly increased ET-1 mRNA expression [14].
###end p 12
###begin p 13
###xml 68 82 68 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 462 464 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 834 836 834 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 848 854 848 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 1039 1041 1039 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 68 81 <span type="species:ncbi:5833">P. falciparum</span>
###xml 999 1004 <span type="species:ncbi:9606">human</span>
###xml 1116 1121 <span type="species:ncbi:9606">human</span>
###xml 1233 1241 <span type="species:ncbi:9606">children</span>
However, co-culture of microvascular endothelial cells treated with P. falciparum parasitized red blood cells (pRBC), but not with uninfected red blood cells (RBC), induced a dose-dependent decrease of ET-1 production [15]. Interactions of endothelins and natriuretic peptides are well described in the literature. CNP is a 22-amino acid peptide that is likely to act as an autocrine or paracrine agent in the CNP-synthesizing tissues, mainly endothelial cells [16]. Unlike the other two members of the Natriuretic Peptide family, the atrial natriuretic peptide (ANP) and the brain natriuretic peptide (BNP), CNP does not have direct natriuretic activity. CNP has been found to be a novel endothelium-derived hyperpolarizing factor that complements the actions of other endothelial vasorelaxant mediators such as NO and prostacyclin [17]. Scotland et al demonstrated that CNP furthermore inhibits leukocyte recruitment and platelet-leukocyte interactions via suppression of P-selectin expression in human umbilical vein endothelial cells [18]. CNP has not been investigated in malaria so far and the role of ET-1 in human falciparum malaria remains unclear. The current study investigates the levels of ET-1 and CNP in the plasma of children with severe and uncomplicated malaria in comparison to healthy controls.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
###xml 15 27 <span type="species:ncbi:9606">participants</span>
Study site and participants
###end title 15
###begin p 16
###xml 214 228 214 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 420 421 420 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 4 12 <span type="species:ncbi:9606">children</span>
###xml 214 227 <span type="species:ncbi:5833">P. falciparum</span>
###xml 274 282 <span type="species:ncbi:9606">children</span>
###xml 479 487 <span type="species:ncbi:9606">patients</span>
All children were consecutively recruited in the paediatric ward of either the Albert Schweitzer Hospital or the Regional Hospital of Lambarene/Gabon between October 2005 and May 2006. The area is hyperendemic for P. falciparum with transmission year-round [19,20]. The 114 children enrolled in the study were both sexes and aged between eight months and seven years. 89 malaria cases and 25 healthy controls (see Table 1) were included. All groups were sex and age matched. All patients and control subjects were included in the study only after signed, informed, parental consent was obtained. The study was approved by the ethics committee of the International Foundation of the Albert Schweitzer Hospital in Lambarene, Gabon.
###end p 16
###begin p 17
Demographic, clinical, and laboratory characteristics of study groups
###end p 17
###begin p 18
###xml 199 200 199 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#215;</sup>
Data are mean (standard deviation), unless otherwise indicated. +Median (interquartile range). Wilcoxon rank sum test was used for testing of statistical significance unless not otherwise indicated. xChi-Square test; double daggerANOVA. NS: not significant. SM: severe malaria; UM: uncomplicated malaria; HC healthy control; sMODS: simplified Multi-Organ-Dysfunction-Score; RBC: red blood cells; Hb: haemoglobin; WBC: white blood cells.
###end p 18
###begin title 19
Clinical definition of malaria and study groups
###end title 19
###begin p 20
###xml 50 64 50 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 326 328 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 400 402 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 50 63 <span type="species:ncbi:5833">P. falciparum</span>
###xml 249 254 <span type="species:ncbi:9606">child</span>
###xml 552 560 <span type="species:ncbi:9606">children</span>
###xml 800 808 <span type="species:ncbi:9606">Children</span>
###xml 1005 1013 <span type="species:ncbi:9606">children</span>
Malaria was defined as a positive blood smear for P. falciparum and presence of fever (axillary temperature >/= 37.5degreesC or rectal temperature >/= 38degreesC) or previous episodes of fever before admission (assessed by parents or guardian) in a child presenting with signs and symptoms of severe or uncomplicated malaria [21]. Severe malaria (SM) was defined according to the WHO criteria (2000 [21]), including hyperparasitaemia (>10% parasitized red blood cells), severe anaemia (haemoglobin <5 g/dL), prostration (inability to sit or in smaller children to drink unaided), jaundice (clinically assessed by examination of conjunctiva and palm of hand or if assessable bilirubin > 3 mg%) or respiratory distress (RD, presence of abnormal deep breathing with nasal flaring, and chest recession). Children with >/= one convulsion within 24 hours before admission and a Blantyre Coma Score (BCS) of </= 2 on admission and no other apparent cause of coma were classified as cerebral malaria. Age-matched children without signs and symptoms of infections at time of investigation and a negative peripheral blood smear for malarial parasites served as healthy controls (HC).
###end p 20
###begin title 21
Blood collection and physical examination
###end title 21
###begin p 22
###xml 601 603 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 604 606 598 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 439 447 <span type="species:ncbi:9606">patients</span>
Venous blood samples were collected, on admission before starting treatment and 24 hours after admission, using sterile Sarstaedt S-Monovette citrate plasma tubes containing 0.106 molar citrate. Plasma was obtained by centrifugation at 3,000 rcf for 10 min within 30 min of blood collection and it was stored at -80degreesC until use. The physical examination on admission was conducted by the same investigator and the clinical course of patients was reported until discharge. In the course of the physical examination on admission the simplified Multi-Organ-Dysfunction-Score (sMODS) was performed [22,23], assessing clinical parameters of disease severity in 10 different organ systems.
###end p 22
###begin title 23
###xml 14 22 <span type="species:ncbi:9606">patients</span>
Management of patients
###end title 23
###begin p 24
###xml 31 39 <span type="species:ncbi:9606">patients</span>
###xml 78 85 <span type="species:ncbi:50278|species:ncbi:153742">quinine</span>
According to local guidelines, patients with SM were treated with intravenous quinine or sulphadoxine-pyrimethamine in case of uncomplicated malaria.
###end p 24
###begin title 25
Laboratory analysis
###end title 25
###begin p 26
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
White and red blood cell counts, haemoglobin (Hb) levels and platelets were determined using an automated haematology analyzer. Parasitological analysis and assessment of parasitaemia was done according to the Lambarene method [24]. Thick blood films were Giemsa stained and examined by two different experienced microscopists. Slides were considered to be negative if parasites were not detected after examination of 100 oil-immersion fields of the thick smear.
###end p 26
###begin title 27
ET-1 and NT-proCNP assays
###end title 27
###begin p 28
Plasma concentrations of ET-1 and NT-proCNP were measured using commercial enzyme-linked immunosorbent assays (ELISA) (BI-20052 and BI-20872, Biomedica Group, Vienna, Austria) in accordance with the manufacturer's instructions. Natriuretic peptides are produced as propeptides, which are subsequentially cleaved to the biologically active, C-terminal hormone and the N-terminal fragment (NT-proCNP). The N-terminal fragments are more stable, they are easier and more reliable to be measured in plasma, therefore we decided to use the sandwich immunoassay for NT-proCNP.
###end p 28
###begin title 29
Statistical analysis
###end title 29
###begin p 30
###xml 1139 1140 1139 1140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
In order to reach equal variance and normal distribution, data of ET-1 and CNP plasma levels were logarithmically transformed. Levels of ET-1 and CNP were compared between the groups of interest using one-way ANOVA. P-values for post-hoc analysis were Bonferroni corrected. Additionally, non-transformed ET-1 and CNP plasma levels were tested by non-parametrical tests - Kruskal-Wallis Test and Dunn's post test for multiple comparisons between groups of interest and Wilcoxon rank sum test when only two groups were compared. As no difference in significances was found between parametrical and non-parametrical tests, results are shown for parametrical testing. Repeated measures of ET-1 and CNP levels were analysed by paired Students-t test. For non-normally distributed data Kruskal-Wallis Test and Wilcoxon rank sum test (when only two groups were compared), were used respectively. Proportions were analysed by Chi-square test. Correlations between different variables were analysed by Pearson correlation and Spearman's rank respectively depending on the distribution of the data. Statistical significance was defined as two-sided p-value < 0.05. Calculations were done using SPSS 15 (Insightful Corporation, Chicago, USA), graphs were drawn by GraphPad Prism version 5.00 (GraphPad Software, San Diego, USA).
###end p 30
###begin title 31
Results
###end title 31
###begin title 32
Characteristics of study population
###end title 32
###begin p 33
###xml 26 40 26 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 90 92 90 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 105 107 105 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 149 151 149 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 256 257 256 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 718 720 718 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 12 20 <span type="species:ncbi:9606">children</span>
###xml 26 39 <span type="species:ncbi:5833">P. falciparum</span>
###xml 126 134 <span type="species:ncbi:9606">children</span>
###xml 269 277 <span type="species:ncbi:9606">patients</span>
###xml 319 327 <span type="species:ncbi:9606">patients</span>
###xml 412 420 <span type="species:ncbi:9606">patients</span>
###xml 464 472 <span type="species:ncbi:9606">children</span>
###xml 603 611 <span type="species:ncbi:9606">children</span>
Eighty-nine children with P. falciparum malaria were enrolled in the study, which had SM (n = 50) or UM (n = 39). Twenty-five children served as HC (n = 25). Demographic, clinical, and laboratory characteristics of the study groups are summarized in Table 1. Out of 50 patients with SM, 20 had severe anaemia (40%), 26 patients (52%) had one or more convulsions within the last 24 hours before admission and six patients (12%) showed hyperparasitaemia. Thirty-two children (64%) were prostrated, 20 had impaired consciousness (40%), 25 showed jaundice (50%) and 23 had respiratory distress (46%). Seven children (14%) fulfilled WHO criteria to be classified as CM. The sMODS was significantly higher in SM than in UM (p < 0.001).
###end p 33
###begin title 34
Plasma levels of ET-1 and NT-proCNP
###end title 34
###begin p 35
###xml 99 101 99 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 143 145 143 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 236 238 236 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 282 284 282 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 374 376 374 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 496 498 496 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 573 575 573 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 599 601 599 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 627 628 627 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 59 67 <span type="species:ncbi:9606">patients</span>
###xml 171 179 <span type="species:ncbi:9606">patients</span>
###xml 301 309 <span type="species:ncbi:9606">patients</span>
###xml 314 322 <span type="species:ncbi:9606">patients</span>
###xml 418 426 <span type="species:ncbi:9606">patients</span>
###xml 610 618 <span type="species:ncbi:9606">patients</span>
ET-1 serum levels were significantly higher in all malaria patients compared with HC on admission (p < 0.001) and after 24 hours of treatment (p = 0.018). On admission UM patients showed significantly higher levels when compared to HC (p < 0.001) and a trend towards higher levels (p = 0.085) than SM patients. SM patients also had significantly higher ET-1 levels than HC (p = 0.029). After 24 hours of treatment, UM patients still showed significantly higher ET-1 levels when compared with HC (p = 0.019), but a significant difference was seen neither between SM and HC (p = 0.249) nor SM and UM (p = 0.474) patients (Figure 1).
###end p 35
###begin p 36
###xml 0 26 0 26 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Endothelin-1 plasma levels</bold>
###xml 426 428 426 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 438 440 438 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 451 453 451 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 80 88 <span type="species:ncbi:9606">children</span>
Endothelin-1 plasma levels. Circulating plasma levels of endothelin-1 (ET-1) in children with severe malaria (SM, square dots), uncomplicated malaria (UM, triangle dots) on admission to hospital and after 24 hours of treatment and healthy controls (HC, round dots), determined using ELISA-technique. Scatter plots, lines indicate Median values. Analyses by ANOVA, p-values were Bonferroni corrected for multiple comparisons. *p < 0.05, **p < 0.01, ***p < 0.001
###end p 36
###begin p 37
###xml 75 77 75 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 149 151 149 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 238 240 238 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 336 338 336 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 421 423 421 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 507 509 507 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 634 635 634 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 26 34 <span type="species:ncbi:9606">patients</span>
###xml 90 98 <span type="species:ncbi:9606">patients</span>
###xml 178 186 <span type="species:ncbi:9606">patients</span>
###xml 291 299 <span type="species:ncbi:9606">patients</span>
###xml 378 386 <span type="species:ncbi:9606">patients</span>
On admission, all malaria patients showed lower CNP levels compared to HC (p = 0.024). SM patients had significantly lower NT-proCNP levels than HC (p = 0.034), but levels of UM patients were not statistically different to those from HC (p = 0.254). After 24 hours of treatment, all malaria patients showed lower levels compared to HC (p = 0.009). NT-proCNP plasma levels of UM patients were significantly lower than HC (p = 0.043) and SM still showed a trend towards lower NT-proCNP levels compared to HC (p = 0.069). Neither on admission nor after 24 hours of treatment was any significant difference seen between UM and SM (Figure 2).
###end p 37
###begin p 38
###xml 0 23 0 23 <bold xmlns:xlink="http://www.w3.org/1999/xlink">NT-proCNP plasma levels</bold>
###xml 440 442 440 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 452 454 452 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 465 467 465 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 94 102 <span type="species:ncbi:9606">children</span>
NT-proCNP plasma levels. Circulating plasma levels NT-pro C-type natriuretic peptide (CNP) in children with severe malaria (SM, square dots), uncomplicated malaria (UM, triangle dots) on admission to hospital and after 24 hours of treatment and healthy controls (HC, round dots), determined using ELISA-technique. Scatter plots, lines indicate Median values. Analyses by ANOVA, p-values were Bonferroni corrected for multiple comparisons. *p < 0.05, **p < 0.01, ***p < 0.001
###end p 38
###begin title 39
Clinical correlations with ET-1 plasma levels
###end title 39
###begin p 40
###xml 103 105 103 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 0 8 <span type="species:ncbi:9606">Children</span>
Children with severe anaemia within the SM group yielded significantly lower ET-1 levels on admission (p = 0.041).
###end p 40
###begin title 41
Discussion
###end title 41
###begin p 42
###xml 92 106 92 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 92 105 <span type="species:ncbi:5833">P. falciparum</span>
In this study, it is shown that ET-1 is significantly higher and CNP significantly lower in P. falciparum malaria compared to healthy controls, i.e. opposed plasma levels of ET-1 and CNP.
###end p 42
###begin p 43
###xml 17 31 17 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 446 447 446 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 448 450 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 603 605 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 606 608 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 654 655 654 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 705 707 705 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 17 30 <span type="species:ncbi:5833">P. falciparum</span>
A key feature of P. falciparum malaria pathogenesis is the activation of the vascular endothelium due to - amongst others - the production of pro-inflammatory mediators such as cytokines and chemokines, resulting in up-regulation of adhesion molecules and sequestration of pRBCs, mononuclear leukocytes and platelets [25,26]. Both ET-1 and CNP are produced mainly by vascular endothelium and act locally as paracrine regulators of vascular tone [6,27]. Pathways of CNP and ET-1 synthesis from pro-CNP and pro-ET-1, respectively, are similar as they both require furin-mediated processing of precursors [28,29]. However, ET-1 is a potent vasoconstrictor [6] whereas CNP has strong vasorelaxant properties [17].
###end p 43
###begin p 44
###xml 125 131 125 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 403 409 403 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 863 865 863 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 866 868 866 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 80 88 <span type="species:ncbi:9606">patients</span>
###xml 361 365 <span type="species:ncbi:10090">mice</span>
###xml 448 453 <span type="species:ncbi:9606">human</span>
###xml 497 502 <span type="species:ncbi:9606">human</span>
These findings correspond well with elevated plasma levels of big ET-1 found in patients with complicated malaria by Wenisch et al [13]. Furthermore, it has been shown that expression of several components of the endothelin pathway including ET-1, endothelin converting enzyme (ECE), and the endothelin receptors A and B (ETA and ETB) are markedly increased in mice with cerebral malaria [14]. Basilico et al investigated the production of ET-1 by human microvascular endothelial cells (HMEC) and human umbilical vein endothelial cells (HUVEC), co-cultured with pRBCs. ET-1 production in both HMEC-1 and HUVEC was increased by hypoxia and Interleukin 1 beta (IL1-beta). However, both normoxic ET-1 production as well as hypoxia- or IL1-beta-induced ET-1 production was reduced in a dose-dependent manner by co-incubation with pRBCs, but not with uninfected RBCs [30,31].
###end p 44
###begin p 45
###xml 390 396 390 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1154 1156 1154 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1157 1159 1157 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 253 261 <span type="species:ncbi:9606">patients</span>
###xml 635 643 <span type="species:ncbi:9606">patients</span>
###xml 1049 1055 <span type="species:ncbi:10090">murine</span>
The results of this study demonstrate a trend towards lower ET-1 levels in SM compared to UM. As circulating pRBCs do not reflect the degree of endothelial cell activation and pRBC sequestration in the microvasculature, the decreasing ET-1 levels in SM patients could indirectly represent inhibition of endothelial ET-1 production by sequestered pRBCs, as demonstrated in vitro by Basilico et al [15]. This might be the reason for the lack of correlation between parasitaemia, ET-1 levels and clinical disease severity. Another reason for the observed trend towards lower ET-1 levels together with significantly lower CNP levels in SM patients could be endothelial cell damage during SM. Pro-inflammatory up-regulation of adhesion molecules with intense sequestration could provoke subsequent cell damage with either inhibition or inability to increase the production of endothelial substances such as ET-1 or CNP in SM. Endothelial cell damage and its impact on the clinical course of malaria is not yet clear. However, in vitro studies as well as murine experiments indicate important vulnerability of endothelial cells during severe/cerebral malaria [31,32].
###end p 45
###begin p 46
###xml 413 419 413 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 567 569 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 637 639 637 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 715 716 715 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 717 719 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 720 722 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 736 742 736 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 911 913 911 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1033 1039 1033 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 1386 1388 1386 1388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1389 1391 1389 1391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1546 1547 1546 1547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1548 1550 1548 1550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1551 1553 1551 1553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 2005 2007 2005 2007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 135 143 <span type="species:ncbi:9606">children</span>
###xml 504 509 <span type="species:ncbi:9606">human</span>
###xml 820 826 <span type="species:ncbi:10090">murine</span>
###xml 848 852 <span type="species:ncbi:10090">mice</span>
###xml 1995 2003 <span type="species:ncbi:9606">patients</span>
The current findings demonstrate an imbalance between vasoconstricitve and vasorelaxant endothelium-derived substances, circulating in children with falciparum malaria. The preponderance of vasoconstrictive effects may not only be due to elevated ET-1 and decreased CNP levels, but also indirectly via impaired endothelial nitric oxide (NO) production, one of the main endothelium-derived relaxing factors. Razmy et al were able to establish a link between ET-1 and NO production, which was decreased in human saphenous vein endothelial cells after exposure to ET-1 [33]. NO has host protective and anti-inflammatory roles (reviewed in [34]) and its functions have been studied extensively in malaria (reviewed in [2,33-37]). Gramaglia et al could recently show that low NO bioavailability contributes to the genesis of murine cerebral malaria and mice treated with exogenous NO did not develop severe malaria [38]. Similar to NO, CNP may exhibit not only vasodilatory but also anti-inflammatory actions in the vasculature. Scotland et al demonstrated that CNP modulates leukocyte-endothelial interactions by down-regulating P-selectin expression directly suppressing leukocyte recruitment. In addition, platelet aggregation and platelet-leukocyte interactions were inhibited by a CNP-mediated suppression of P-selectin expression on platelets indicating an antithrombotic role of CNP [17,18]. As upregulation of adhesion molecules, activation and sequestration of platelets, leukocytes, pRBCs and RBCs are important features of SM pathogenesis [2,25,39], the findings of low CNP levels in the SM group could be interpreted as an insufficient counterregulatory CNP upregulation - with its possible protective anti-inflammatory and vasodilatory effects - probably due to endothelial damage as mentioned above. Similarly to these findings of low CNP levels in SM we had already described significantly lower levels of tissue inhibitor of matrix metalloproteinases-2 (TIMP-2) in the same cohort of patients [40].
###end p 46
###begin p 47
###xml 135 141 135 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 238 241 <span type="species:ncbi:10116">rat</span>
However, it has to be considered that plasma levels do not truly reflect the microvascular situation at the site of inflammation. Said et al described increased ET-1 levels which were more pronounced in mucosal tissue than in plasma in a rat model of stress-induced mucosal haemorrhage [41]. ET-1 and CNP may act in a paracrine fashion, therefore a correlation between circulating plasma ET-1 and CNP concentration and disease severity might not directly reflect the pathogenetic importance of ET-1 and CNP in severe malaria.
###end p 47
###begin p 48
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 225 231 225 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 390 397 <span type="species:ncbi:50278|species:ncbi:153742">quinine</span>
###xml 420 428 <span type="species:ncbi:9606">patients</span>
###xml 479 486 <span type="species:ncbi:50278|species:ncbi:153742">quinine</span>
###xml 559 566 <span type="species:ncbi:50278|species:ncbi:153742">quinine</span>
A possible interaction of treatment with plasma levels of ET-1 may also be taken into consideration. An inhibitory effect on ET-1 production in HUVECs has been shown for substances such as ursodeoxycholic acid [42]. Del Pozo et al described a downward shift of contractions of isolated thoracic aortic rings induced by endothelin-1 in response to a pretreatment with high concentrations of quinine [43]. All the studied patients with severe malaria were treated with intravenous quinine, according to local guidelines. Whether schizonticidal therapy, such as quinine, and host-derived endothelial peptides, such as ET-1 and CNP, may interact at a circulating enzyme level or could be more pronounced at receptor levels is still insufficiently investigated and, therefore, poses an important research challenge.
###end p 48
###begin title 49
Conclusion
###end title 49
###begin p 50
The pathophysiological significance of ET-1 and CNP in malaria is still an open-ended question. Many factors contribute to the course of malaria (eg, pro-inflammatory mediators, sequestration, endothelial activation), thus, it is difficult to assess the contributory role of two specific factors. However, the results of this study provide evidence for an involvement of substances produced in the endothelium in SM pathogenesis and underline the importance of further investigation of the vascular compartment, in particular endothelial cells, and their contribution to the development of the devastating multi-organ complications defining severe malaria.
###end p 50
###begin title 51
Competing interests
###end title 51
###begin p 52
The authors declare that they have no competing interests.
###end p 52
###begin title 53
Authors' contributions
###end title 53
###begin p 54
AD, PL, RH and ES study design, analysis of data, draft of manuscript; AD and KS sample collection and immunoassays, SI and BL sample collection, critical reading of the manuscript, MR critical reading of the manuscript, PGK: study design, critical reading of the manuscript. All authors read and approved the final manuscript.
###end p 54
###begin article-title 55
World malaria report 2005
###end article-title 55
###begin article-title 56
Cerebral malaria - a neurovascular pathology with many riddles still to be solved
###end article-title 56
###begin article-title 57
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human cerebral malaria and the blood-brain barrier
###end article-title 57
###begin article-title 58
###xml 62 83 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Platelets potentiate brain endothelial alterations induced by Plasmodium falciparum
###end article-title 58
###begin article-title 59
Evolving functions of endothelial cells in inflammation
###end article-title 59
###begin article-title 60
Endothelin system: the double-edged sword in health and disease
###end article-title 60
###begin article-title 61
###xml 56 61 <span type="species:ncbi:9606">human</span>
Endothelin induction of adhesion molecule expression on human brain microvascular endothelial cells
###end article-title 61
###begin article-title 62
Different endothelins stimulate cytokine production by peritoneal macrophages and microglial cell line
###end article-title 62
###begin article-title 63
The endothelin system in septic and endotoxin shock
###end article-title 63
###begin article-title 64
###xml 37 45 <span type="species:ncbi:9606">patients</span>
Plasma endothelin-1 levels in septic patients
###end article-title 64
###begin article-title 65
The role of endothelin in the pathogenesis of Chagas' disease
###end article-title 65
###begin article-title 66
###xml 82 90 <span type="species:ncbi:9606">patients</span>
Endothelin-1 precursor peptides correlate with severity of disease and outcome in patients with community acquired pneumonia
###end article-title 66
###begin article-title 67
###xml 44 66 44 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 18 26 <span type="species:ncbi:9606">patients</span>
###xml 44 65 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Big endothelin in patients with complicated Plasmodium falciparum malaria
###end article-title 67
###begin article-title 68
###xml 16 22 <span type="species:ncbi:10090">murine</span>
Endothelin in a murine model of cerebral malaria
###end article-title 68
###begin article-title 69
###xml 0 22 0 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 0 21 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 93 98 <span type="species:ncbi:9606">human</span>
Plasmodium falciparum parasitized red blood cells modulate the production of endothelin-1 by human endothelial cells
###end article-title 69
###begin article-title 70
C-type natriuretic peptide: an important neuroendocrine regulator?
###end article-title 70
###begin article-title 71
C-type natriuretic peptide in vascular physiology and disease
###end article-title 71
###begin article-title 72
C-type natriuretic peptide inhibits leukocyte recruitment and platelet-leukocyte interactions via suppression of P-selectin expression
###end article-title 72
###begin article-title 73
Mosquito distribution and entomological inoculation rates in three malaria-endemic areas in Gabon
###end article-title 73
###begin article-title 74
Malaria epidemiology in the province of Moyen Ogoov, Gabon
###end article-title 74
###begin article-title 75
Severe falciparum malaria
###end article-title 75
###begin article-title 76
###xml 116 138 116 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 116 137 <span type="species:ncbi:5833">Plasmodium falciparum</span>
The use of the multi-organ-dysfunction score to discriminate different levels of severity in severe and complicated Plasmodium falciparum malaria
###end article-title 76
###begin article-title 77
###xml 86 108 86 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 72 80 <span type="species:ncbi:9606">children</span>
###xml 86 107 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Simplified multi-organ dysfunction score predicts disability in African children with Plasmodium falciparum malaria
###end article-title 77
###begin article-title 78
###xml 61 69 <span type="species:ncbi:9606">children</span>
Comparison of methods for the rapid laboratory assessment of children with malaria
###end article-title 78
###begin article-title 79
Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria
###end article-title 79
###begin article-title 80
The microcirculation in severe malaria
###end article-title 80
###begin article-title 81
Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system"
###end article-title 81
###begin article-title 82
Processing of proendothelin-1 by members of the subtilisin-like pro-protein convertase family
###end article-title 82
###begin article-title 83
Furin-mediated processing of Pro-C-type natriuretic peptide
###end article-title 83
###begin article-title 84
###xml 78 100 78 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 78 99 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Endothelin-1 production by a microvascular endothelial cell line treated with Plasmodium falciparum parasitized red blood cells
###end article-title 84
###begin article-title 85
###xml 0 22 0 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 0 21 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Plasmodium falciparum malaria: reduction of endothelial cell apoptosis in vitro
###end article-title 85
###begin article-title 86
Apoptosis in experimental cerebral malaria: spatial profile of cleaved caspase-3 and ultrastructural alterations in different disease stages
###end article-title 86
###begin article-title 87
Elevated endothelin-1 levels impair nitric oxide homeostasis through a PKC-dependent pathway
###end article-title 87
###begin article-title 88
Anti-inflammatory mechanisms in the vascular wall
###end article-title 88
###begin article-title 89
###xml 135 157 135 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 135 156 <span type="species:ncbi:5833">Plasmodium falciparum</span>
High plasma levels of nitrogen oxides are associated with severe disease and correlate with rapid parasitological and clinical cure in Plasmodium falciparum malaria
###end article-title 89
###begin article-title 90
Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria
###end article-title 90
###begin article-title 91
Nitric oxide synthase 2 (Lambarene) (G-954C), increased nitric oxide production, and protection against malaria
###end article-title 91
###begin article-title 92
Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria
###end article-title 92
###begin article-title 93
The pathogenic basis of malaria
###end article-title 93
###begin article-title 94
###xml 65 87 65 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 65 86 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Matrix metalloproteinases and their tissue inhibitors (TIMPs) in Plasmodium falciparum malaria: serum levels of TIMP-1 are associated with disease severity
###end article-title 94
###begin article-title 95
###xml 95 99 <span type="species:ncbi:10116">rats</span>
Role of endogenous endothelin-1 in stress-induced gastric mucosal damage and acid secretion in rats
###end article-title 95
###begin article-title 96
###xml 57 62 <span type="species:ncbi:9606">human</span>
Ursodeoxycholic acid inhibits endothelin-1 production in human vascular endothelial cells
###end article-title 96
###begin article-title 97
###xml 58 65 <span type="species:ncbi:50278|species:ncbi:153742">quinine</span>
###xml 120 123 <span type="species:ncbi:10116">rat</span>
Stereoselective effects of the enantiomers, quinidine and quinine, on depolarization- and agonist-mediated responses in rat isolated aorta
###end article-title 97

